Genetic Background of Polycythemia Vera

Polycythemia vera belongs to myeloproliferative neoplasms, essentially by affecting the erythroblastic lineage. JAK2 alterations have emerged as major driver mutations triggering PV-phenotype with the <i>V617F</i> mutation detected in nearly 98% of cases. That’s why JAK2 targeting therap...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Mathilde Regimbeau, Romain Mary, François Hermetet, François Girodon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2022-04-01
Saila:Genes
Gaiak:
polycythemia vera
<i>JAK2</i> mutation
erythrocytosis
myeloproliferative neoplasm
mutational landscape
Sarrera elektronikoa:https://www.mdpi.com/2073-4425/13/4/637
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak